TREATMENT OF CANCER WITH TOR KINASE INHIBITORS Provided herein are methods for treating or preventing ETS overexpressing castration-resistant prostate cancer, comprising administering an effective amount of a TOR kinase inhibitor to a patient having ETS overexpressing castration-resistant prostate cancer.
申请公布号
AU2013202992(A1)
申请公布日期
2013.10.03
申请号
AU20130202992
申请日期
2013.03.14
申请人
SIGNAL PHARMACEUTICALS, LLC
发明人
XU, SHULCHAN;HEGE, KRISTEN;RAYMON, HEATHER;TSUJI, TOSHIYA;SAPINOSO, LISA
